Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results, Provides Business Update

~ Achieved total net sales of $7.3 million in the second quarter of 2024 ~

~ Appointed Jeffrey S. Hackman as Chief Executive Officer (CEO) and member of the Board of Directors ~

~ Company has approximately $43 million in cash, cash equivalents and investment securities ~

Related Posts